In Vivo Augmentation of Natural Killer Activity by Combined Treatment with Recombinant Gamma Interferon and Interleukin-2
Authors:
- M. Refaat ShalabyMSM. Refaat Shalaby
- Lloyd P. SvederskyLSLloyd P. Svedersky
- Patrick A. MckayPMPatrick A. Mckay
- Bryan S. FinkleBFBryan S. Finkle
- Michael A. PalladinoMPMichael A. Palladino
- 1 January 1985
- journal article
- Published by SAGE Publications in Journal of Interferon Research
- Vol. 5 (4) , 571-581
Abstract
The in vivo regulation of natural killer (NK) cell function by recombinant murine gamma interferon (rMuIFN-gamma) and recombinant human interleukin-2 (rHuIL-2) was investigated. Peritoneal exudate-derived natural killer (PE-NK) cells of mice treated with rMuIFN-gamma or rHuIL-2 exhibited significantly enhanced cytolytic activities against YAC-1 target cells. Compared with animals receiving treatment with either rMuIFN-gamma or rHuIL-2 alone, the sequential treatment of mice with both agents resulted in a significantly greater enhancement of PE-NK cell function, especially when rMuIFN-gamma was administered 24 h before treatment with rHuIL-2. The cytolytic activities were significantly diminished after pretreatment of effector cells with anti-Qa-5 antiserum and complement but not with anti-Lyt-3.2 antiserum. These data constitute the first evidence demonstrating the association between IFN-gamma and IL-2 in the regulation of NK cell function in vivo, reinforce the potential benefit of combined treatment with biological response modifiers, and show that the schedule of administration may be a critical requirement for optimal benefits of combined lymphokine treatment in vivo.Keywords
This publication has 27 references indexed in Scilit:
- Purified human interleukin-2 enhances induction of immune interferonCellular Immunology, 1983
- Natural killer cell activity and spontaneous development of lymphoma. Effects of single and multiple injections of interferon into young and aged C57BL/6 miceInternational Journal of Cancer, 1983
- The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3.Journal of Experimental Medicine, 1983
- The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptorsCellular Immunology, 1983
- On the heterogeneity of murine natural killer cells.Journal of Experimental Medicine, 1981
- Heterogeneity of natural killer cells in the mouse.Journal of Experimental Medicine, 1981
- Interleukin-2 augments natural killer cell activityNature, 1981
- Ontogeny of murine T lymphocytesCellular Immunology, 1981
- Enhancement by interferon of natural killer cell activity in miceCellular Immunology, 1979
- Enhanced NK cell activity in mice injected with interferon and interferon inducersNature, 1978